Immuron (IMRN) Interest Coverage Ratio (2017 - 2024)
Immuron (IMRN) recorded quarterly Interest Coverage Ratio of 631383620.69 in Q4 2024, down 125243619.8% quarter-over-quarter from 504.12 in Q4 2023, and down 125243619.8% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Interest Coverage Ratio (2017 - 2024) Analysis & Trends
Immuron's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 631383620.69 for Q4 2024.
- In Q4 2024, Interest Coverage Ratio fell 125243619.8% year-over-year to 631383620.69; the TTM figure through Dec 2024 stood at 631382658.57 (down 19079.9% YoY), while the FY2025 annual figure was 731.63, up 4.45% from the prior year.
- Interest Coverage Ratio was 631383620.69 for Q4 2024 at Immuron, down from 504.12 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1396085889.57 in Q4 2021 to a low of 631383620.69 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 152940699.68 across 5 years, with a median of 504.12 in 2023.
- The sharpest annual moves came in 2021 and 2024: Interest Coverage Ratio jumped 193212570.22% in 2021, then tumbled 125243619.8% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 722.56 in 2020, then surged by 193212570.22% to 1396085889.57 in 2021, then sank by 100.0% to 2.83 in 2022, then jumped by 17736.64% to 504.12 in 2023, then sank by 125243619.8% to 631383620.69 in 2024.
- The last three Interest Coverage Ratio figures came in at 631383620.69 (Q4 2024), 504.12 (Q4 2023), and 2.83 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -631.38 Mn |
| Dec 31, 2023 | 504.12 |
| Dec 31, 2022 | 2.83 |
| Dec 31, 2021 | 1.40 Bn |
| Dec 31, 2020 | 722.56 |
| Dec 31, 2019 | 647.54 |
| Dec 31, 2017 | -1,306.58 |